ACCELERATE YOUR TIME-TO-MARKET WITH VALUABLE MARKET ACCESS INTEL
The 21st Annual Market Access Summit returns to Toronto in 2022 with leaders from across Canada’s healthcare stakeholder groups. Secure your spot today and:
Engage in dialogue with key regulators and decision-makers on raising the rate of new product introductions.
Strategize with your peers regarding price increases in light of the apparent minimization of PMPRB influence.
Optimize your new drug listing agreements (PLAs) in the face of an ever-changing landscape.
Stay on top of new provincial developments with insight from Canada’s leading regulators.
Achieve successful rare disease drug launches with a thorough understanding of COVID-19’s impact on the new government framework.
Benchmark best practices with 20+ pharmaceutical, regulatory and government speakers.
Get your ticket to join experts from Canada’s top pharmaceutical, regulatory and biotech companies, including Takeda, Pfizer, Bayer, Biogen, CADTH, INESSS, Knight Therapeutics, Paladin Labs, Mitsubishi Tanabe Pharma Canada and many more.
This year’s edition is an in-personevent featuring interactive sessions and face-to-face networking opportunities. The conference will also be streamed virtually for increased reach and higher engagement.
The Market Access Summit brings together the biggest names in Canada’s healthcare vertical and provides them with leading solutions. It enables them to access strategically focused content in an environment conducive to forging lasting business partnerships.
This is your opportunity to cultivate relationships with the industry’s key influencers and buyers at this exclusive event. Build your pipeline with qualified sales leads by taking advantage of one of our limited sponsorship opportunities now.